Yenerel, Mustafa N. http://orcid.org/0000-0002-6473-1342
Sicre de Fontbrune, Flore
Piatek, Caroline
Sahin, Fahri
Füreder, Wolfgang
Ortiz, Stephan
Ogawa, Masayo
Ozol-Godfrey, Ayca
Sierra, J. Rafael
Szer, Jeff
Clinical trials referenced in this document:
Documents that mention this clinical trial
Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up
https://doi.org/10.1007/s12325-022-02339-3
Funding for this research was provided by:
Alexion, AstraZeneca Rare Disease
Article History
Received: 8 August 2022
Accepted: 26 September 2022
First Online: 22 October 2022